OUR SOLUTIONS
Solutions for Pharmaceutical Manufacturers
Our customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.
LEARN MORE
Solutions for Healthcare IT
Let our unbeatable covered lives methodology and innovative technology inform your market access strategy.
LEARN MORE
Solutions for Payers, Providers & Pharmacies
Establish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.
LEARN MORE
Newest Solution
Quickly analyze and visualize real-world patient datasets to instantly obtain answers to access barriers and prescribing patterns.
LEARN MOREPress Release
MMIT Announces the Winners of the Q4 2022 Patient Access Awards
Payers and physicians recognize manufacturers across seven therapeutic areas who are dedicated to smoothing patient access.
“Ryan [Witherington] and the team at MMIT have been great partners in our initiatives to analyze and communicate payer policy data for our product through innovative field tools, both MMIT-developed and developed by us using MMIT data. FormTrak Web, in particular, has been well-received by our field sales team and we are excited to transition to FormTrak in Veeva to streamline the process and make it an even more valuable tool.”
— Director of Market Access, Large Pharma Company
Subscribe to MMIT's Thought Leadership
Get the latest from MMIT’s leading subject matter experts, receiving the latest posts right to your inbox. Top-quality thought leadership 100% free.
Removing Access Barriers for Long-Acting Injectables
Manufacturers with LAIs in the pipeline will need to be mindful about the persistent barriers to access faced by drugs with this formulation.
Industry Insights
MMIT offers a range of publications for pharma, payers and providers covering news, strategy and insights across the spectrum. Our in-house journalism division AIS Health provides objective news and analysis of industry trends while RJ Health provides a comprehensive look at industry updates as they apply to medically covered drug reimbursement processes.